Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease-Reference-Cited by-同舟云学术

Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease

Published:2015-03-03 Issue:1 Volume:45 Page:35-43
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Jongbloed Wesley¹²,Bruggink Kim A.³,Kester Maartje I.²,Visser Pieter-Jelle²⁴,Scheltens Philip²,Blankenstein Marinus A.¹,Verbeek Marcel M.³,Teunissen Charlotte E.¹,Veerhuis Robert¹⁵

Affiliation:

1. Department of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands

2. Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands

3. Department of Neurology, Department of Laboratory Medicine, Donders Institute for Brain, Cognition and behaviour, Alzheimer Centre Nijmegen, Radboud University Medical Centre, Nijmegen, The Netherlands

4. Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, University of Maastricht, Maastricht, The Netherlands

5. Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathology;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

2. Advances in nanoprobes for molecular MRI of Alzheimer's disease;WIREs Nanomedicine and Nanobiotechnology;2024-03

3. Sugar distributions on gangliosides guide the formation and stability of amyloid-β oligomers;Biophysical Chemistry;2023-09

4. α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation;Journal of the American Chemical Society;2023-08-09

5. CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease;International Journal of Molecular Sciences;2023-05-19